Business
– Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced that all proposals were approved at its Annual General Meeting of Shareholders held earlier today. These proposals included...
Hi, what are you looking for?
Jewish Business News
All posts tagged "Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)"
Business
– Bristol-Myers Squibb’s Baraclude has $314 million in US annual sales. – – Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced that the U.S. Court...
Court
– Teva Receives Favorable Court Decision Regarding Generic Celebrex® Capsules; Teva Should Receive Sole Exclusivity for Generic Celebrex Capsules. – – Teva Pharmaceutical Industries...
Business
– Teva CSO Dr. Michael Hayden: We are disappointed with these results. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) today announced...
Business
– Teva and Takeda Agree to Commercialize Rasagiline for Parkinson’s Disease Treatment in Japan. – Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) and Takeda Pharmaceutical Company...
Court
– The US Supreme Court has in effect allowed generic versions of the MS drug from next month. – – Teva Pharmaceutical Industries Ltd. TEVATEVA (NYSE: ;...
Court
– Brand Celebrex has $2.2 billion in US sales in 2013, according to IMS data. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced today that its...
StartUps
– Teva has 180 days of marketing exclusivity for generic Evista, which had 2013 US sales of $824 million. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)...
StartUps
– The first and only orally inhaled medicine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults. –...
Business
– Europe’s Committee for Medicinal Products for Human Use: The risk-benefit profile of laquinimod is not favorable at this time. – – Teva Pharmaceutical...